메뉴 건너뛰기




Volumn 6, Issue 10, 2014, Pages 738-744

Lipid-lowering agents in the management of nonalcoholic fatty liver disease

Author keywords

Cardiovascular disease; Colesevelam; Ezetimibe; Fibrates; Nicotinic acid; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Omega 3 fatty acids; Statins; Transaminases

Indexed keywords


EID: 84909988804     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v6.i10.738     Document Type: Short Survey
Times cited : (22)

References (62)
  • 1
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • PMID: 22488764
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023 [PMID: 22488764 DOI: 10.1002/hep.25762]
    • (2012) Hepatology , vol.55 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6    Charlton, M.7    Sanyal, A.J.8
  • 2
    • 77953971188 scopus 로고    scopus 로고
    • Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
    • PMID: 20581244
    • Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-974 [PMID: 20581244 DOI: 10.1136/gut.2009.205088]
    • (2010) Gut , vol.59 , pp. 969-974
    • Wong, V.W.1    Wong, G.L.2    Choi, P.C.3    Chan, A.W.4    Li, M.K.5    Chan, H.Y.6    Chim, A.M.7    Yu, J.8    Sung, J.J.9    Chan, H.L.10
  • 3
    • 11144351102 scopus 로고    scopus 로고
    • The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
    • PMID: 15629518
    • Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138 [PMID: 15629518 DOI: 10.1016/j.jhep.2004.09.012]
    • (2005) J Hepatol , vol.42 , pp. 132-138
    • Adams, L.A.1    Sanderson, S.2    Lindor, K.D.3    Angulo, P.4
  • 5
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
    • PMID: 20858492
    • Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131 [PMID: 20858492 DOI: 10.1053/j.gastro.2010.09.038]
    • (2011) Gastroenterology , vol.140 , pp. 124-131
    • Williams, C.D.1    Stengel, J.2    Asike, M.I.3    Torres, D.M.4    Shaw, J.5    Contreras, M.6    Landt, C.L.7    Harrison, S.A.8
  • 6
    • 79957449923 scopus 로고    scopus 로고
    • Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
    • e1; quiz e60, PMID: 21440669
    • Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-530. e1; quiz e60 [PMID: 21440669 DOI: 10.1016/j.cgh.2011.03.020]
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 524-530
    • Younossi, Z.M.1    Stepanova, M.2    Afendy, M.3    Fang, Y.4    Younossi, Y.5    Mir, H.6    Srishord, M.7
  • 7
    • 33746421488 scopus 로고    scopus 로고
    • Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease
    • PMID: 16732016
    • Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330 [PMID: 16732016 DOI: 10.2337/dc06-0135]
    • (2006) Diabetes Care , vol.29 , pp. 1325-1330
    • Targher, G.1    Bertolini, L.2    Padovani, R.3    Rodella, S.4    Zoppini, G.5    Zenari, L.6    Cigolini, M.7    Falezza, G.8    Arcaro, G.9
  • 8
    • 50849096389 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review
    • PMID: 18672311
    • Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49: 600-607 [PMID: 18672311 DOI: 10.1016/j.jhep.2008.06.012]
    • (2008) J Hepatol , vol.49 , pp. 600-607
    • Sookoian, S.1    Pirola, C.J.2
  • 9
    • 34247605492 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
    • PMID: 17277038
    • Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-1218 [PMID: 17277038 DOI: 10.2337/dc06-2247]
    • (2007) Diabetes Care , vol.30 , pp. 1212-1218
    • Targher, G.1    Bertolini, L.2    Padovani, R.3    Rodella, S.4    Tessari, R.5    Zenari, L.6    Day, C.7    Arcaro, G.8
  • 10
    • 22344452893 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: a population-based cohort study
    • PMID: 16012941
    • Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121 [PMID: 16012941 DOI: 10.1053/j.gastro.2005.04.014]
    • (2005) Gastroenterology , vol.129 , pp. 113-121
    • Adams, L.A.1    Lymp, J.F.2    St Sauver, J.3    Sanderson, S.O.4    Lindor, K.D.5    Feldstein, A.6    Angulo, P.7
  • 12
    • 34547673500 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients
    • PMID: 17519430
    • Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30: 2119-2121 [PMID: 17519430 DOI: 10.2337/dc07-0349]
    • (2007) Diabetes Care , vol.30 , pp. 2119-2121
    • Targher, G.1    Bertolini, L.2    Rodella, S.3    Tessari, R.4    Zenari, L.5    Lippi, G.6    Arcaro, G.7
  • 14
    • 0031947715 scopus 로고    scopus 로고
    • Steatohepatitis: a tale of two "hits"?
    • PMID: 9547102
    • Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845 [PMID: 9547102 DOI: 10.1016/S0016-5085(98)70599-2]
    • (1998) Gastroenterology , vol.114 , pp. 842-845
    • Day, C.P.1    James, O.F.2
  • 15
    • 84897449323 scopus 로고    scopus 로고
    • Inhibition of apoptosis in the management of nonalcoholic fatty liver disease
    • PMID: 23516172
    • Bouziana SD, Tziomalos K. Inhibition of apoptosis in the management of nonalcoholic fatty liver disease. World J Gastrointest Pharmacol Ther 2013; 4: 4-8 [PMID: 23516172 DOI: 10.4292/wjgpt.v4.i1.4]
    • (2013) World J Gastrointest Pharmacol Ther , vol.4 , pp. 4-8
    • Bouziana, S.D.1    Tziomalos, K.2
  • 16
    • 84886906559 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment
    • PMID: 23355909
    • Paschos P, Tziomalos K. Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment. World J Hepatol 2012; 4: 327-331 [PMID: 23355909 DOI: 10.4254/wjh.v4.i12.327]
    • (2012) World J Hepatol , vol.4 , pp. 327-331
    • Paschos, P.1    Tziomalos, K.2
  • 17
    • 84857132090 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options
    • PMID: 22239625
    • Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. Curr Vasc Pharmacol 2012; 10: 162-172 [PMID: 22239625 DOI: 10.2174/157016112799305012]
    • (2012) Curr Vasc Pharmacol , vol.10 , pp. 162-172
    • Tziomalos, K.1    Athyros, V.G.2    Karagiannis, A.3
  • 18
    • 77957375969 scopus 로고    scopus 로고
    • Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
    • PMID: 20879883
    • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350 [PMID: 20879883 DOI: 10.1056/NEJMra0912063]
    • (2010) N Engl J Med , vol.363 , pp. 1341-1350
    • Targher, G.1    Day, C.P.2    Bonora, E.3
  • 19
    • 36549034768 scopus 로고    scopus 로고
    • Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths
    • PMID: 18061058
    • Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 1829-1839 [PMID: 18061058 DOI: 10.1016/S0140-6736(07)61778-4]
    • (2007) Lancet , vol.370 , pp. 1829-1839
    • Lewington, S.1    Whitlock, G.2    Clarke, R.3    Sherliker, P.4    Emberson, J.5    Halsey, J.6    Qizilbash, N.7    Peto, R.8    Collins, R.9
  • 20
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials
    • PMID: 21067804
    • Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681 [PMID: 21067804 DOI: 10.1016/S0140-6736(10)61350-5]
    • (2010) Lancet , vol.376 , pp. 1670-1681
    • Baigent, C.1    Blackwell, L.2    Emberson, J.3    Holland, L.E.4    Reith, C.5    Bhala, N.6    Peto, R.7    Barnes, E.H.8    Keech, A.9    Simes, J.10    Collins, R.11
  • 21
    • 35748962429 scopus 로고    scopus 로고
    • The safety of statins in clinical practice
    • PMID: 17559928
    • Armitage J. The safety of statins in clinical practice. Lancet 2007; 370: 1781-1790 [PMID: 17559928 DOI: 10.1016/S0140-6736(07)60716-8]
    • (2007) Lancet , vol.370 , pp. 1781-1790
    • Armitage, J.1
  • 23
    • 78649890465 scopus 로고    scopus 로고
    • Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
    • PMID: 21109302
    • Athyros VG, Tziomalos K, Gossios TD, Griva T, Anagnostis P, Kargiotis K, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-1922 [PMID: 21109302 DOI: 10.1016/S0140-6736(10)61272-X]
    • (2010) Lancet , vol.376 , pp. 1916-1922
    • Athyros, V.G.1    Tziomalos, K.2    Gossios, T.D.3    Griva, T.4    Anagnostis, P.5    Kargiotis, K.6    Pagourelias, E.D.7    Theocharidou, E.8    Karagiannis, A.9    Mikhailidis, D.P.10
  • 24
    • 84886254094 scopus 로고    scopus 로고
    • Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-tomoderate baseline elevations in alanine aminotransferase levels
    • PMID: 24001698
    • Tikkanen MJ, Fayyad R, Faergeman O, Olsson AG, Wun CC, Laskey R, Kastelein JJ, Holme I, Pedersen TR. Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-tomoderate baseline elevations in alanine aminotransferase levels. Int J Cardiol 2013; 168: 3846-3852 [PMID: 24001698 DOI: 10.1016/j.ijcard.2013.06.024]
    • (2013) Int J Cardiol , vol.168 , pp. 3846-3852
    • Tikkanen, M.J.1    Fayyad, R.2    Faergeman, O.3    Olsson, A.G.4    Wun, C.C.5    Laskey, R.6    Kastelein, J.J.7    Holme, I.8    Pedersen, T.R.9
  • 25
    • 2142768218 scopus 로고    scopus 로고
    • Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
    • PMID: 15131789
    • Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology 2004; 126: 1287-1292 [PMID: 15131789 DOI: 10.1053/j.gastro.2004.02.015]
    • (2004) Gastroenterology , vol.126 , pp. 1287-1292
    • Chalasani, N.1    Aljadhey, H.2    Kesterson, J.3    Murray, M.D.4    Hall, S.D.5
  • 26
    • 0037150209 scopus 로고    scopus 로고
    • Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project
    • PMID: 12021218
    • Pfeffer MA, Keech A, Sacks FM, Cobbe SM, Tonkin A, Byington RP, Davis BR, Friedman CP, Braunwald E. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Circulation 2002; 105: 2341-2346 [PMID: 12021218 DOI: 10.1161/01. CIR.0000017634.00171.24]
    • (2002) Circulation , vol.105 , pp. 2341-2346
    • Pfeffer, M.A.1    Keech, A.2    Sacks, F.M.3    Cobbe, S.M.4    Tonkin, A.5    Byington, R.P.6    Davis, B.R.7    Friedman, C.P.8    Braunwald, E.9
  • 27
    • 81555203011 scopus 로고    scopus 로고
    • Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
    • PMID: 22291824
    • Athyros VG, Giouleme O, Ganotakis ES, Elisaf M, Tziomalos K, Vassiliadis T, Liberopoulos EN, Theocharidou E, Karagiannis A, Mikhailidis DP. Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci 2011; 7: 796-805 [PMID: 22291824 DOI: 10.5114/aoms.2011.25554]
    • (2011) Arch Med Sci , vol.7 , pp. 796-805
    • Athyros, V.G.1    Giouleme, O.2    Ganotakis, E.S.3    Elisaf, M.4    Tziomalos, K.5    Vassiliadis, T.6    Liberopoulos, E.N.7    Theocharidou, E.8    Karagiannis, A.9    Mikhailidis, D.P.10
  • 28
  • 30
    • 79953880237 scopus 로고    scopus 로고
    • Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
    • PMID: 21476786
    • Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011; 43: 167-171 [PMID: 21476786 DOI: 10.3109/07853890.2011.561363]
    • (2011) Ann Med , vol.43 , pp. 167-171
    • Athyros, V.G.1    Tziomalos, K.2    Daskalopoulos, G.N.3    Karagiannis, A.4    Mikhailidis, D.P.5
  • 31
    • 2342456307 scopus 로고    scopus 로고
    • Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study
    • PMID: 15135271
    • Rallidis LS, Drakoulis CK, Parasi AS. Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study. Atherosclerosis 2004; 174: 193-196 [PMID: 15135271 DOI: 10.1016/j.atherosclerosis.2004.01.008]
    • (2004) Atherosclerosis , vol.174 , pp. 193-196
    • Rallidis, L.S.1    Drakoulis, C.K.2    Parasi, A.S.3
  • 32
    • 34047271926 scopus 로고    scopus 로고
    • Therapeutic options in nonalcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study
    • PMID: 17410287
    • Georgescu EF, Georgescu M. Therapeutic options in nonalcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. J Gastrointestin Liver Dis 2007; 16: 39-46 [PMID: 17410287]
    • (2007) J Gastrointestin Liver Dis , vol.16 , pp. 39-46
    • Georgescu, E.F.1    Georgescu, M.2
  • 33
    • 77955664397 scopus 로고    scopus 로고
    • Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
    • PMID: 20112031
    • Kimura Y, Hyogo H, Yamagishi S, Takeuchi M, Ishitobi T, Nabeshima Y, Arihiro K, Chayama K. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroenterol 2010; 45: 750-757 [PMID: 20112031 DOI: 10.1007/s00535-010-0203-y]
    • (2010) J Gastroenterol , vol.45 , pp. 750-757
    • Kimura, Y.1    Hyogo, H.2    Yamagishi, S.3    Takeuchi, M.4    Ishitobi, T.5    Nabeshima, Y.6    Arihiro, K.7    Chayama, K.8
  • 34
    • 55649083505 scopus 로고    scopus 로고
    • Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
    • PMID: 19013295
    • Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, Ishitobi T, Nonaka M, Chayama K. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Metabolism 2008; 57: 1711-1718 [PMID: 19013295 DOI: 10.1016/j.metabol.2008.07.030]
    • (2008) Metabolism , vol.57 , pp. 1711-1718
    • Hyogo, H.1    Tazuma, S.2    Arihiro, K.3    Iwamoto, K.4    Nabeshima, Y.5    Inoue, M.6    Ishitobi, T.7    Nonaka, M.8    Chayama, K.9
  • 35
    • 84910010800 scopus 로고    scopus 로고
    • Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report
    • PMID: 24805248
    • Kargiotis K, Katsiki N, Athyros VG, Giouleme O, Patsiaoura K, Katsiki E, Mikhailidis DP, Karagiannis A. Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report. Curr Vasc Pharmacol 2014; 12: 505-511 [PMID: 24805248]
    • (2014) Curr Vasc Pharmacol , vol.12 , pp. 505-511
    • Kargiotis, K.1    Katsiki, N.2    Athyros, V.G.3    Giouleme, O.4    Patsiaoura, K.5    Katsiki, E.6    Mikhailidis, D.P.7    Karagiannis, A.8
  • 36
    • 74949102941 scopus 로고    scopus 로고
    • A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial
    • PMID: 19448566
    • Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial. J Clin Gastroenterol 2009; 43: 990-994 [PMID: 19448566 DOI: 10.1097/MCG.0b013e31819c392e]
    • (2009) J Clin Gastroenterol , vol.43 , pp. 990-994
    • Nelson, A.1    Torres, D.M.2    Morgan, A.E.3    Fincke, C.4    Harrison, S.A.5
  • 37
    • 84881491358 scopus 로고    scopus 로고
    • Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis
    • PMID: 23063971
    • Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology 2013; 144: 323-332 [PMID: 23063971 DOI: 10.1053/j.gastro.2012.10.005]
    • (2013) Gastroenterology , vol.144 , pp. 323-332
    • Singh, S.1    Singh, P.P.2    Singh, A.G.3    Murad, M.H.4    Sanchez, W.5
  • 38
    • 84863115964 scopus 로고    scopus 로고
    • Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection
    • PMID: 22271485
    • Tsan YT, Lee CH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012; 30: 623-630 [PMID: 22271485 DOI: 10.1200/JCO.2011.36.0917]
    • (2012) J Clin Oncol , vol.30 , pp. 623-630
    • Tsan, Y.T.1    Lee, C.H.2    Wang, J.D.3    Chen, P.C.4
  • 39
    • 84876516919 scopus 로고    scopus 로고
    • Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection
    • PMID: 23509319
    • Tsan YT, Lee CH, Ho WC, Lin MH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol 2013; 31: 1514-1521 [PMID: 23509319 DOI: 10.1200/JCO.2012.44.6831]
    • (2013) J Clin Oncol , vol.31 , pp. 1514-1521
    • Tsan, Y.T.1    Lee, C.H.2    Ho, W.C.3    Lin, M.H.4    Wang, J.D.5    Chen, P.C.6
  • 40
    • 34548125027 scopus 로고    scopus 로고
    • Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy
    • PMID: 17659159
    • Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin 2007; 23: 2009-2026 [PMID: 17659159 DOI: 10.1185/030079907X210507]
    • (2007) Curr Med Res Opin , vol.23 , pp. 2009-2026
    • Mikhailidis, D.P.1    Sibbring, G.C.2    Ballantyne, C.M.3    Davies, G.M.4    Catapano, A.L.5
  • 41
    • 77955519012 scopus 로고    scopus 로고
    • NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
    • PMID: 20222991
    • Enjoji M, Machida K, Kohjima M, Kato M, Kotoh K, Matsunaga K, Nakashima M, Nakamuta M. NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Lipids Health Dis 2010; 9: 29 [PMID: 20222991 DOI: 10.1186/1476-511X-9-29]
    • (2010) Lipids Health Dis , vol.9 , pp. 29
    • Enjoji, M.1    Machida, K.2    Kohjima, M.3    Kato, M.4    Kotoh, K.5    Matsunaga, K.6    Nakashima, M.7    Nakamuta, M.8
  • 45
    • 84878626719 scopus 로고    scopus 로고
    • Colesevelam: a new and improved bile acid sequestrant?
    • PMID: 23317402
    • Tziomalos K, Karagiannis A, Mikhailidis DP, Athyros VG. Colesevelam: a new and improved bile acid sequestrant? Curr Pharm Des 2013; 19: 3115-3123 [PMID: 23317402 DOI: 10.2174/1381612811319170019]
    • (2013) Curr Pharm Des , vol.19 , pp. 3115-3123
    • Tziomalos, K.1    Karagiannis, A.2    Mikhailidis, D.P.3    Athyros, V.G.4
  • 46
    • 84865569519 scopus 로고    scopus 로고
    • Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial
    • PMID: 22431131
    • Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, Cohen BL, Brenner D, Sirlin C, Loomba R. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012; 56: 922-932 [PMID: 22431131 DOI: 10.1002/hep.25731]
    • (2012) Hepatology , vol.56 , pp. 922-932
    • Le, T.A.1    Chen, J.2    Changchien, C.3    Peterson, M.R.4    Kono, Y.5    Patton, H.6    Cohen, B.L.7    Brenner, D.8    Sirlin, C.9    Loomba, R.10
  • 47
    • 46449124024 scopus 로고    scopus 로고
    • Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol
    • PMID: 18049900
    • Merat S, Aduli M, Kazemi R, Sotoudeh M, Sedighi N, Sohrabi M, Malekzadeh R. Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol. Dig Dis Sci 2008; 53: 2246-2250 [PMID: 18049900 DOI: 10.1007/s10620-007-0109-6]
    • (2008) Dig Dis Sci , vol.53 , pp. 2246-2250
    • Merat, S.1    Aduli, M.2    Kazemi, R.3    Sotoudeh, M.4    Sedighi, N.5    Sohrabi, M.6    Malekzadeh, R.7
  • 48
    • 84898597579 scopus 로고    scopus 로고
    • Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study
    • Apr 17, Epub ahead of print, PMID: 23607264
    • Ishitobi T, Hyogo H, Tokumo H, Arihiro K, Chayama K. Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study. Hepatol Res 2013 Apr 17; Epub ahead of print [PMID: 23607264 DOI: 10.1111/hepr.12135]
    • (2013) Hepatol Res
    • Ishitobi, T.1    Hyogo, H.2    Tokumo, H.3    Arihiro, K.4    Chayama, K.5
  • 49
    • 0021350001 scopus 로고
    • The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
    • PMID: 6361299
    • The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-364 [PMID: 6361299 DOI: 10.1001/jama.1984.03340270029025]
    • (1984) JAMA , vol.251 , pp. 351-364
  • 51
    • 77954519409 scopus 로고    scopus 로고
    • Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease
    • PMID: 20371660
    • Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, Klein S. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2010; 95: 2727-2735 [PMID: 20371660 DOI: 10.1210/jc.2009-2622]
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 2727-2735
    • Fabbrini, E.1    Mohammed, B.S.2    Korenblat, K.M.3    Magkos, F.4    McCrea, J.5    Patterson, B.W.6    Klein, S.7
  • 58
    • 63449137594 scopus 로고    scopus 로고
    • Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
    • PMID: 19009658
    • Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 2008; 14: 6395-6400 [PMID: 19009658 DOI: 10.3748/wjg.14.6395]
    • (2008) World J Gastroenterol , vol.14 , pp. 6395-6400
    • Zhu, F.S.1    Liu, S.2    Chen, X.M.3    Huang, Z.G.4    Zhang, D.W.5
  • 59
    • 41349102802 scopus 로고    scopus 로고
    • Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
    • PMID: 18277895
    • Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008; 42: 413-418 [PMID: 18277895 DOI: 10.1097/MCG.0b013e31815591aa]
    • (2008) J Clin Gastroenterol , vol.42 , pp. 413-418
    • Tanaka, N.1    Sano, K.2    Horiuchi, A.3    Tanaka, E.4    Kiyosawa, K.5    Aoyama, T.6
  • 61
    • 84877299845 scopus 로고    scopus 로고
    • HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
    • PMID: 23444397
    • HPS2-THRIVE Collaborative Group. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur Heart J 2013; 34: 1279-1291 [PMID: 23444397 DOI: 10.1093/eurheartj/eht055]
    • (2013) Eur Heart J , vol.34 , pp. 1279-1291
  • 62
    • 84910016169 scopus 로고    scopus 로고
    • Niacin causes serious unexpected sideeffects, but no worthwhile benefits, for patients who are at increased risk of heart attacks and strokes
    • updated 2013 March 9; cited, May 17, Available from: URL
    • HPS2-THRIVE. Niacin causes serious unexpected sideeffects, but no worthwhile benefits, for patients who are at increased risk of heart attacks and strokes (updated 2013 March 9; cited 2014 May 17). Available from: URL: http://www.thrivestudy.org/press_release.htm
    • (2014)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.